Altria Group, Inc.
Altria Reports Q3 2024 Results and Reaffirms Full-Year Guidance
Summary
Altria Group, Inc. announced its financial results for Q3 2024, reporting an increase in net revenues and adjusted diluted earnings per share (EPS). The company also reaffirmed its full-year 2024 earnings guidance, which includes the impact of special items such as a gain from the sale of IQOS commercialization rights and charges for NJOY acquisition. Altria continued to return capital to shareholders through share repurchases and dividend payments, with a focus on transitioning adult smokers to smoke-free products.
Profitelligence Alerts
Get alerts for MO
Be first to know when Altria Group, Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Altria Group, Inc.
Altria Group, Inc. is a holding company with a primary focus on the manufacture and sale of cigarettes and related products. Serving as a leading player in the tobacco industry, Altria is best known for its premium cigarette brand, Marlboro, which holds a significant market share in the United States. Beyond cigarettes, the company has established a diversified portfolio by investing in smokeless tobacco products, wine via its subsidiary Ste. Michelle Wine Estates, and a stake in the cannabis market through its investment in Cronos Group. Altria's strategic expansions into non-cigarette categories reflect its aim to navigate changing consumer preferences and regulatory landscapes. As one of the foremost publicly traded entities in its sector, Altria plays a significant role in the broader consumer goods market. The company continues to engage with shifting market dynamics by fostering innovation in reduced-risk products while maintaining its strong presence in traditional tobacco markets.
Official SEC Documents
Advertisement